Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Stabilizers, specifically referring to mast cell stabilizers such as cromolyn sodium, have scientific validation for their use in treating respiratory allergies, including allergic rhinitis and allergic asthma. Mast cell stabilizers work by preventing the release of histamine and other inflammatory mediators from mast cells, which are key players in allergic reactions. Cromolyn sodium, for example, has been extensively studied and is approved for use in the prevention and management of symptoms associated with respiratory allergies.

Clinical trials have demonstrated that intranasal and inhaled cromolyn sodium can reduce symptoms of allergic rhinitis and help prevent asthma attacks triggered by allergens. The medication is particularly useful for individuals who cannot tolerate first-line treatments such as corticosteroids or antihistamines. Several guidelines, including those from the American Academy of Allergy, Asthma & Immunology (AAAAI), mention mast cell stabilizers as an option for mild to moderate cases or as adjunct therapy.

However, mast cell stabilizers are generally considered less effective than corticosteroids but have a favorable safety profile, making them suitable for certain populations, such as children and pregnant women. Their effect is preventive rather than immediate; regular use is required to maintain benefit. In summary, the use of mast cell stabilizers for respiratory allergies is supported by robust scientific evidence and clinical guidelines.

More about Stabilizers
More about Allergies (respiratory)

Other ingredients used for Allergies (respiratory)

Other health conditions supported by Stabilizers

Products containing Stabilizers